MedTrace Logo

Back to the Traditional: Anti-COX Drugs Can Improve the Outcome of COVID-19 Patients Admitted to ICU

NCT04757792 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 475

Last updated 2021-02-17

No results posted yet for this study

Summary

Retrospective multicenter study to evaluate the data of COVID-19 patients who were admitted to university hospitals in relation to their recent administration or maintenance on non-steroidal anti-inflammatory drugs (NSAID) prior to have COVID-19 disease and to analyze it in relation to outcome of these patients.

Conditions

  • COVID-19 Disease

Interventions

OTHER

File inquiry

Data extraction out of file registry

Sponsors & Collaborators

  • Tanta University

    collaborator OTHER

  • Cairo University

    collaborator OTHER

  • Benha University

    lead OTHER

Principal Investigators

  • Adel Alkholy, Prof · Faculty of medicine, Banha University, Egypt

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-06
Primary Completion
2021-02-01
Completion
2021-02-11

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04757792 on ClinicalTrials.gov